Clinical Trials Browser

Phase 2 × Glioblastoma × cabazitaxel × Clear all

NCT01866449 2017-10-26

Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme

Phase 2 Completed

Glioblastoma